Browsing Tag
oncology immunotherapy
2 posts
A durability breakthrough or early signal? What pelareorep means for resistant colorectal cancer
Can durability redefine MSS colorectal cancer? Discover how Oncolytics Biotech, Inc.’s pelareorep data could shift treatment strategy and market dynamics.
PDS Biotechnology Corporation strengthens PDS0101 intellectual property ahead of key regulatory milestones
PDS Biotechnology strengthens PDS0101 patent protection ahead of key Phase 3 and regulatory milestones. Find out what this means for investors.